Form 4: Athira Pharma VP of Finance, Robert Renninger, Acquires Shares Through Stock Options and Restricted Stock Units

Robert Renninger, VP of Finance at Athira Pharma, reports acquisition of shares through stock options and restricted stock units.

Summary

• On October 1, 2024, Robert Renninger, the VP of Finance at Athira Pharma, acquired 37,077 Restricted Stock Units (RSUs) and stock options, each representing the right to buy one share of Athira Pharma's common stock.
• The stock options have an exercise price of $0.4499.
• The RSUs and stock options vest in three equal installments on December 31, 2024, June 30, 2025, and December 31, 2025, contingent upon continued service with the company.
• Following these transactions, Renninger directly owns 37,077 shares of Athira Pharma's common stock through these derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice, and the vesting schedule indicates confidence in the company's future. There are no explicitly negative indicators.

Positives

• The acquisition of RSUs and stock options by a key executive signals confidence in the company's future performance.
• The vesting schedule incentivizes continued service and commitment from the VP of Finance.

Future Outlook

The vesting schedule of the RSUs and stock options suggests an expectation of continued service and contribution from the VP of Finance over the next year.

Industry Context

Stock option and RSU grants are common practices in the pharmaceutical industry to incentivize and retain key personnel, aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Equity compensation packages for VPs of Finance in biotech companies typically include a mix of stock options and restricted stock units.
• The vesting schedules are generally structured to incentivize long-term commitment, often over a 2-3 year period, which aligns with Athira Pharma's vesting schedule.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of management's commitment.
• Employees may be motivated by the fact that key executives are incentivized to improve company performance.

Key Dates